| NCT ID | NCT06927622 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Shandong University |
| Condition | COVID-19 Pneumonia |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2023-04-01 |
| Primary Completion | 2025-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2023-04-01 with a primary completion date of 2025-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to learn about the influence of Corona Virus Disease 2019 on obstetric outcome and offspring development.
Eligibility Criteria
Inclusion Criteria: * Conduct regular prenatal examinations in the hospital and establish a pregnancy and childbirth health manual, planning for pregnant women who are hospitalized for delivery; * Conduct regular physical examinations in the hospital and establish a children's health manual for infants. * Age ≥ 18 years old Exclusion Criteria: * Concomitant tumor related diseases; * Individuals with severe mental disorders.
Contact & Investigator
Fanzhen Hong, Doctorate
STUDY DIRECTOR
The Second Hospital of Shandong University
Frequently Asked Questions
Who can join the NCT06927622 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying COVID-19 Pneumonia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06927622 currently recruiting?
Yes, NCT06927622 is actively recruiting participants. Contact the research team at 202216407@mail.sdu.edu.cn for enrollment information.
Where is the NCT06927622 trial being conducted?
This trial is being conducted at Jinan, China, Jinan, China, Jinan, China, Jinan, China and 1 additional location.
Who is sponsoring the NCT06927622 clinical trial?
NCT06927622 is sponsored by Shandong University. The principal investigator is Fanzhen Hong, Doctorate at The Second Hospital of Shandong University. The trial plans to enroll 1,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.